Medical Cannabis for Cancer: Pain, Nausea and Palliative Care UK

Medical Cannabis for Cancer Patients

Cancer patients represent one of the most important groups accessing medical cannabis in the UK. The evidence across multiple cancer-related indications is among the strongest in cannabis medicine: pain relief, chemotherapy-induced nausea and vomiting (CINV), appetite stimulation, and palliative quality of life.

Cancer Pain

Cancer pain - both from the disease itself and from treatments - is one of the most clinically validated indications for cannabis medicine. Key evidence:

• A 2010 controlled trial of nabiximols (Sativex) in cancer pain refractory to opioids showed significant pain reduction in the low-dose group.
• Multiple systematic reviews confirm cannabis provides meaningful analgesia in cancer pain, particularly neuropathic components.
• The opioid-sparing effect is especially significant in cancer patients, where opioid escalation carries serious quality-of-life costs.

Chemotherapy-Induced Nausea and Vomiting

This is historically the most established cancer indication for cannabinoids. Nabilone - a synthetic cannabinoid - is licensed on the NHS specifically for CINV that has not responded to other antiemetics. It remains the first cannabis medicine to receive NHS approval in any indication.

For patients who do not qualify for Nabilone or who prefer plant-based alternatives, private cannabis clinics can prescribe THC-containing products with strong evidence for antiemetic effects.

Appetite Stimulation and Cachexia

Cancer cachexia - the wasting syndrome affecting up to 80% of advanced cancer patients - responds to THC-based medicines through the well-documented appetite-stimulating (orexigenic) effect of THC. Studies show significant improvements in appetite and caloric intake in cancer patients using cannabis.

Sleep and Quality of Life in Palliative Care

For palliative cancer patients, cannabis addresses multiple symptoms simultaneously - pain, insomnia, anxiety, nausea - making it particularly valuable in end-of-life care. Several UK hospices are now familiar with cannabis medicines and can provide advice on integrating them with palliative protocols.

Getting a Cancer Cannabis Prescription

Cancer patients are priority patients at most UK cannabis clinics. The prescription pathway is typically faster and more straightforward than for other conditions, given the urgency and the strong evidence base. Clinics with specific oncology experience include Integro Medical and Sapphire Medical.